Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by dardanion Jul 12, 2016 1:18pm

92 Views

Post# 25044983

RE:RE:1 to 2 mm tumors...

That's the problem in a nutshell. Some of you folks jump to conclusions without backing up your statements with facts. It all sounds good on the surface but is it factual or is it just conjecture and speculation? Where does it say that the first 9 patients will be picked from a pool of patients with 1 to 2 mm tumors?

Bullboard Posts

Eminent acquires promising Nevada gold project